Patent details
EP2029145 Title: PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES
Basic Information
- Publication number:
- EP2029145
- PCT Application Number:
- PCT/US/2007/069595
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP078119278
- PCT Publication Number:
- WO/2007/140222
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES
- French Title of Invention:
- COMPOSÉS DE PYRROLOPYRIMIDINE ET LEURS UTILISATIONS
- German Title of Invention:
- PYRROLOPYRIMIDINVERBINDUNGEN UND IHRE VERWENDUNGEN
- SPC Number:
Dates
- Filing date:
- 24/05/2007
- Grant date:
- 25/01/2017
- EP Publication Date:
- 25/01/2017
- PCT Publication Date:
- 06/12/2007
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/03/2009
- EP B1 Publication Date:
- 25/01/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 24/05/2017
- Expiration date:
- 24/05/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/05/2007
- Name:
- Astex Therapeutics Limited
- Address:
- 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom (GB)
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- BRAIN Christopher Thomas
- Address:
- United States (US)
2
- Name:
- THOMA Gebhard
- Address:
- Germany (DE)
3
- Name:
- SUNG Moo Je
- Address:
- United States (US)
Priority
- Priority Number:
- 808605 P
- Priority Date:
- 26/05/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/519;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|